Showing results (51-60 of 68) with videos related to
Sort By:
Pageof 7
Advances in Protein Chemistry and Structural Biology|November 27, 2025
Heat shock proteins (HSPs) as chaperones for oncogenesisGunjan Dagar, Ashna Gupta, Manisha Dagar, et al.Cancer Letters|July 30, 2025
ECD co-operates with ERBB2 to promote tumorigenesis through upregulation of unfolded protein response and glycolysisBenjamin B Kennedy, Mohsin Raza, Sameer Mirza, et al.Breast Cancer Research and Treatment|February 22, 2015
The mammalian target of rapamycin complex 1 (mTORC1) in breast cancer: the impact of oestrogen receptor and HER2 pathwaysDena A Jerjees, Ola H Negm, M Layth Alabdullah, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 2024
2D nanostructures: Potential in diagnosis and treatment of Alzheimer's diseaseSaba Tufail, Mohammad Asif Sherwani, Zahid Shamim, et al.Journal of Translational Medicine|July 7, 2023
Harnessing the potential of CAR-T cell therapy: progress, challenges, and future directions in hematological and solid tumor treatmentsGunjan Dagar, Ashna Gupta, Tariq Masoodi, et al.Molecular Cancer Research : MCR|October 21, 2021
Ecdysoneless Protein Regulates Viral and Cellular mRNA Splicing to Promote Cervical OncogenesisSameer Mirza, Achyuth Kalluchi, Mohsin Raza, et al.Cancers|October 6, 2020
Blocking c-MET/ERBB1 Axis Prevents Brain Metastasis in ERBB2+ Breast CancerShailendra K Gautam, Ranjana K Kanchan, Jawed A Siddiqui, et al.Journal of Translational Medicine|April 29, 2025
Human papilloma virus (HPV) mediated cancers: an insightful updateSadaf Khursheed Baba, Shahad Shahdad Eissa Alblooshi, Reem Yaqoob, et al.Breast Cancer Research and Treatment|January 25, 2012
Overexpression of a novel cell cycle regulator ecdysoneless in breast cancer: a marker of poor prognosis in HER2/neu-overexpressing breast cancer patientsXiangshan Zhao, Sameer Mirza, Alaa Alshareeda, et al.BMC Cancer|September 17, 2023
Associations between telomere attrition, genetic variants in telomere maintenance genes, and non-small cell lung cancer risk in the Jammu and Kashmir population of North IndiaGh Rasool Bhat, Rajeshwer Singh Jamwal, Itty Sethi, et al.Pageof 7